Prevalence of HBV and HCV infections and associated risk factors in addict prisoners

Iranian Journal of Public Health

Volumn 35, Issue 4, 2006, Pages 33-36

  Javadi, A A ^a   Avijgan, M ^b   Hafizi, M ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HBV; HCV; Iran; Prisoners; Risk factors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; COMMUNITY; DRUG ABUSE; DRUG DEPENDENCE; HEALTH EDUCATION; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION CONTROL; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRISONER; QUESTIONNAIRE; RISK FACTOR;

EID: 33846599388     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Skipper C, Guy JM, Parket J, Roderick P, Rosenberg WM (2003). Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: Implication for the national strategy. Gut, 52(10): 1500-504.
2. Malekzadeh R, Khatibian M, Rezvan H (1997). Viral hepatitis in the world and Iran. J Irn Med Council, 15: 183-200.
3. Massarrat MS, Tahaghoghi-Mehrizi S (2002). Iranian national health survey: A brief report. Arch Irn Med, 5: 73-9.
4. Pourshams A, Malekzadeh R, Monawari A, Akbari MR, Mohamadkhani A, Yamhmadi S et al. (2005). Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroentrol Hepatol, 20(2): 229-33.
5. Robinsin WS (2000). Hepatitis B virus and Hepatitis D virus. In: Principles and Practice of Infectious Diseases. Eds, Mandell GL, Benette JE, Dolin R. 5th ed, Churchil livingstone Inc. Philadelfia, pp: 1652-68.
6. Hosseini Asl SK, Avijgan M, Mohamadnejad M (2004). High Prevalence of HBV, HCV, and HIV Infections: In Gypsy Population Residing In Shar-e-kord. Arch Iranian Med, 7(1): 22-24.
7. Armele A, Zak Dft Zbar O, Vasseur V (2002). Prevalence of HBV and HCV infection in lasant. Arr Med Interne, 152 (suppl 7): 6-8.
8. Champian JK, Taylor A, Hutchinson S, Cameron S, Mcmenamin J, Mitchell A et al.(2004). Incidence of hepatitis C vires infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol, 159(5): 514-9.
9. Butler TCA, Dolan KA, Ferson MJ, MC Guinness LM, Brown PR, Robertson PW (1997). Hepatitis B and C in New South Wales prison: Prevalence and risk factors. Med J Aust, 166(3): 127-30.
10. Long J. Allwright S, Barry J, Reynolds SR, Thornton L et al. (2001). Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors entrants to Irish prisons: a national cross sectional survey: BMJ, 323(7323): 1209-13.
11. Anonymous (2004). Centers for disease control and prevention. Hepatitis B vaccination of inmates in correctional facilities. 2000-2002. MMWR, 53(30): 681-3.
12. Anonymous (2004). Centers for disease control and prevention. Transmission of hepatitis B virus in correctional facilities. Georgia 1999-2002. MMWR, 53(30): 678-81.
13. Hellard Me, Hocking JS, Croffs N (2004). The prevalence and the risk behaviors associates with transmission of hepatitis C virus in Australian correctional facilities. Epidemical Infect, 132(3): 404-15.
14. Van Ameijden EJ, Van den Hock JA, Mientjes GH, Coutinbo RA (1993). A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amesterdam. Eur J Epidemiol, 9(3): 255-62.
15. Samul MC, Doherty PM, Bulterys M, Jenison SA (2001). Association between heroin use needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in new Mexico USA. Epidemiol Infect, 127(3): 475-84.
16. Chistensen PB, Kraup HB, Niesters HG, Norder H, Georgson J (2000). Prevalence and incidence of blood borne viral infections among Danish prisoners. Eur J Epidemiol, 16(71): 1043-9.
17. Butler TCA, Dolan KA, Ferson MJ, MC Guinness LM, Brown PR, Robertson PW (1997). Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Med J Aust, 166(3): 127-30.
18. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C et al. (2004). Prevalence and incidence of HIV, heaptitis B virus and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health, 94(7): 1218-23.
19. Weild AR, Gill ON, Bennett D, living stone SJ, Parry JV, Curran L (2000). Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Common Dis Public Health, 3(2): 121-6.
20. Solomon L, Flynn C, Muck K, Vertcfeuille J (2004). Prevalence of HIV, Syphilis, Hepatitis B and hepatitis C among entrants to Maryland correctional facilities. J Urban Health, 81(1): 25-37.
21. Weinbaum C, Lyerla R, Margolis HS (2003). Prevention and control of Infection with hepatitis viruses in correctional setting. MMWR Recomm Rep, 52(10): 205-14.
22. Awofeso N (2002). Hepatitis B vaccinations in prisons. Boll World Health Organ. 80(7): 569-74.
23. Jacobs RJ, Rosenthal P, Meyerhoff AS (2004). Cost effectiveness of hepatitis A/B vIrsus hepatitis B vaccination for US prison inmates. Vaccine, 22(9-10): 1241-80.